APA

Snyder D. W., Bach N. J., Dillard R. D., Draheim S. E., Carlson D. G., Fox N., Roehm N. W., Armstrong C. T., Chang C. H., Hartley L. W., Johnson L. M., Roman C. R., Smith A. C., Song M. & Fleisch J. H. (19990401). Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI. : The Journal of pharmacology and experimental therapeutics.

Chicago

Snyder D W, Bach N J, Dillard R D, Draheim S E, Carlson D G, Fox N, Roehm N W, Armstrong C T, Chang C H, Hartley L W, Johnson L M, Roman C R, Smith A C, Song M and Fleisch J H. 19990401. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI. : The Journal of pharmacology and experimental therapeutics.

Harvard

Snyder D. W., Bach N. J., Dillard R. D., Draheim S. E., Carlson D. G., Fox N., Roehm N. W., Armstrong C. T., Chang C. H., Hartley L. W., Johnson L. M., Roman C. R., Smith A. C., Song M. and Fleisch J. H. (19990401). Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI. : The Journal of pharmacology and experimental therapeutics.

MLA

Snyder D W, Bach N J, Dillard R D, Draheim S E, Carlson D G, Fox N, Roehm N W, Armstrong C T, Chang C H, Hartley L W, Johnson L M, Roman C R, Smith A C, Song M and Fleisch J H. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI. : The Journal of pharmacology and experimental therapeutics. 19990401.